chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No Adverse Event; patient was given a 0.25mL dose as a booster dose; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (patient was given a 0.25mL dose as a booster dose) and NO ADVERSE EVENT (No Adverse Event) in a 67-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 050B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 06-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced ACCIDENTAL UNDERDOSE (patient was given a 0.25mL dose as a booster dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, ACCIDENTAL UNDERDOSE (patient was given a 0.25mL dose as a booster dose) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (patient was given a 0.25mL dose as a booster dose).    No concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Bivalent Moderna vaccine was administered by mistake as a primary series dose; No Adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Bivalent Moderna vaccine was administered by mistake as a primary series dose) and NO ADVERSE EVENT (No Adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    In November 2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Bivalent Moderna vaccine was administered by mistake as a primary series dose) and NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Bivalent Moderna vaccine was administered by mistake as a primary series dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Bivalent Moderna vaccine was administered by mistake as a primary series dose).    No relevant concomitant medications were reported.  No treatment information was provided.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No Adverse Event; first dose was given 10SEP2022 and the second dose second dose given on 2OCT2022; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was given 10SEP2022 and the second dose second dose given on 2OCT2022) and NO ADVERSE EVENT (No Adverse Event) in a 19-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 059A22A) for COVID-19 prophylaxis.     It was unknown  if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.    On 10-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-Oct-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to .5 milliliter. On 02-Oct-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was given 10SEP2022 and the second dose second dose given on 2OCT2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was given 10SEP2022 and the second dose second dose given on 2OCT2022) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was given 10SEP2022 and the second dose second dose given on 2OCT2022).    Concomitant medication list was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; Patient just received the second vaccine. First dose was administered around MAY2022.; Dose administered after the published expiration date on 27NOV2022.; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient just received the second vaccine. First dose was administered around MAY2022.), EXPIRED PRODUCT ADMINISTERED (Dose administered after the published expiration date on 27NOV2022.) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 082B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Dec-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 06-Dec-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient just received the second vaccine. First dose was administered around MAY2022.) and EXPIRED PRODUCT ADMINISTERED (Dose administered after the published expiration date on 27NOV2022.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient just received the second vaccine. First dose was administered around MAY2022.), EXPIRED PRODUCT ADMINISTERED (Dose administered after the published expiration date on 27NOV2022.) and NO ADVERSE EVENT (No adverse event) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient just received the second vaccine. First dose was administered around MAY2022.) and EXPIRED PRODUCT ADMINISTERED (Dose administered after the published expiration date on 27NOV2022.).    No concomitant medications were reported.  Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. First primary series dose given in April 2022. No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date) and NO ADVERSE EVENT (No adverse event) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 019H22A) for COVID-19 prophylaxis.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:asthma and hypertension.  Concurrent medical conditions included Asthma and Hypertension.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date).    No concomitant medicine were reported. Patient identifiers for patient number 7 are documented in this case. No treatment medicine were reported.
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: sick; Initial information was received 04-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves an unknown age and unknown gender patient who experienced sick while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (lot number, expiry date: not reported) via unknown route in unknown administration site (form, strength: unknown) for prophylactic vaccination.  On an unknown date the patient developed a non-serious event of sick (illness) (latency: Unknown) following the administration of influenza vaccine.  It was reported, " I got my flu shot and just got over a raging case of influenza A...I was so sick...even with a flu shot."  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Age: 0.67
Sex: F
Vaccine: HIBV
Symptoms: Medication error, No adverse event, Product preparation error
Clinical narrative: missed this vaccine when administered Quadracel/missed the ACTHIB portion not in this vaccine with no reported adverse event; Initial information received on 02-Dec-2022 regarding an unsolicited valid  non-serious case via other health professional.  This case involves a 8-month-old female patient who missed this vaccine when administered Quadracel/missed the ACTHIB portion not in this vaccine with no reported adverse event after receiving HIB (PRP/T) vaccine [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis B vaccine (Hepatitis B Vaccine); and pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13).  On an unknown date, the patient received an unknown dose of suspect HIB (PRP/T) vaccine Powder and solvent for solution for injection (strength, expiry date, batch lot number: unknown) via unknown route in unknown administration site for immunization. Information on batch number and expiry date was requested.  On 16-Nov-2022 the patient had a non-serious event of missed this vaccine when administered Quadracel/missed the ACTHIB portion not in this vaccine with no reported adverse event (product preparation issue) (unknown latency) following the administration of HIB (PRP/T) vaccine.  Action taken with haemophilus type B (HIB) vaccine (ACT-HIB) was not applicable.  Outcome: Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2022SA496172:01390021
Age: 57.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: Death of relative, Dizziness, Hallucination, visual
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Additional Details: pt reported dizzy after receiving moderna bivalent shot; pt also was seeing "evil spirits"; he has history of bipolar and his sister recently passed away
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site bruising, Injection site erythema, Injection site pruritus, Injection site swelling, Pruritus
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: pt reported on 12/5/2022. pt claims that rash was all over body, back, arms, legs and buttocks. she only used benadryl otc. rash resolved after 3 weeks per pt
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: pt reported on 12/5/2022. pt claims that rash was all over body, back, arms, legs and buttocks. she only used benadryl otc. rash resolved after 3 weeks per pt
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anaphylactic reaction, Dysphagia, Dyspnoea, Eye swelling, Injection site bruising
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: pt's freind reported similar side effects for her and Pt. pt's friend claims that pt has generalized rash that started when she got hom. ras was on back, neck, buttocks, arms and legs. she claims that pt used benadryl otc and benadryl cream. rash resolved after aproximately 21 days
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Mouth swelling
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: pt's freind reported similar side effects for her and Pt. pt's friend claims that pt has generalized rash that started when she got hom. ras was on back, neck, buttocks, arms and legs. she claims that pt used benadryl otc and benadryl cream. rash resolved after aproximately 21 days
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pruritus, Rash, Swelling face, Swollen tongue, Throat tightness
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: pt's freind reported similar side effects for her and Pt. pt's friend claims that pt has generalized rash that started when she got hom. ras was on back, neck, buttocks, arms and legs. she claims that pt used benadryl otc and benadryl cream. rash resolved after aproximately 21 days
Age: 77.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Neuralgia
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Severe, Additional Details: Patient stated having increased nerve pain from injection site down to her fingers, and has visible red bruise from injection site
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Eczema, Rash
Clinical narrative: Skin rash with bubbles (looks like eczema) on left arm, left chest, and left back
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 40.0
Sex: F
Vaccine: TD
Symptoms: Injection site cellulitis
Clinical narrative: Cellulitis developed at site of injection which may have been a little too low. Treated with topical mupirocin and systemic amoxicillin/clavulanate for 5 days
Sex: M
Vaccine: FLUX
Symptoms: Muscle twitching
Clinical narrative: TWITCHING FACIAL; A spontaneous report has been received from the regulatory authority concerning a male patient of Unknown ethnic origin (age 11 years).    No medical history was reported. The following demography was reported for the patient's parent:   Sex: Unknown. Concomitant medication included clobazam for epilepsy.     On 30-Nov-2022, the patient received Live Influenza Virus (influenza vaccine live reassort 4v) (batch number PH3539), via nasal route, for flu vaccination.    No malfunction has been reported for LIVE INFLUENZA VIRUS.    On 30-Nov-2022, the patient experienced twitching facial (preferred term: Muscle twitching).     It is unknown if any action was taken with Live Influenza Virus.     At the time of reporting, the outcome of the event was unknown.    Reporter assessed the event was considered serious due to important medical event.     Device Information:     Combination Product Report: Yes    Product As Reported: LIVE INFLUENZA VIRUS  Common Device Name: Nasal Spray  Procode: CCQ  Product Role: Suspect
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given her second dose of moderna on 12/06/2022 and the vaccine expired on 12/2/22
Age: 37.0
Sex: F
Vaccine: COVID19-2
Symptoms: Alopecia, Aphonia, Dyspnoea, Insomnia, Paranasal sinus discomfort
Clinical narrative: I had a breakthrough case, tickle in throat, shortness of breath, congestion insomnia, hair loss. Lost my voice, sinus pressure.
Age: 37.0
Sex: F
Vaccine: COVID19-2
Symptoms: Polymerase chain reaction, Respiratory tract congestion, Throat irritation, Vaccine breakthrough infection
Clinical narrative: I had a breakthrough case, tickle in throat, shortness of breath, congestion insomnia, hair loss. Lost my voice, sinus pressure.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19
Clinical narrative: Hospitalization for general weakness due to COVID-19 on dates 11/28/2022- 12/1/2022. Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19
Clinical narrative: Hospitalization for Acute Repiratory Failure due to COVID-19 on dates 11/28/2022- 12/5/2022. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Incorrect product formulation administered
Clinical narrative: Error in administration, a second dose was administered that did not correspond to the patient it was 37 days after the first dose. He only had one dose. First Dose 10/13-2022 Second Dose that was not correspondent because it was monovalent 11-21-2022. Monovalent 11-21-2022.
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, Body temperature increased, COVID-19, Chills
Clinical narrative: Symptoms began Saturday November 26th at two AM, they include up to 102 degrees, headaches, body aches chills slight congestion and then around eight PM the same I experienced confusion and ringing in the ears. Sunday November 27 2022 I took a home COVID-19 test that resulted in positive. On Monday 28 2022 I contacted my PCP who prescribed an antiviral I began taking the antiviral on Tuesday November 29 and began to see a reduction in symptoms by Thursday December first symptoms had dissipated other than a loss of taste and smell.
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: Confusional state, Headache, Malaise, Pain, Respiratory tract congestion
Clinical narrative: Symptoms began Saturday November 26th at two AM, they include up to 102 degrees, headaches, body aches chills slight congestion and then around eight PM the same I experienced confusion and ringing in the ears. Sunday November 27 2022 I took a home COVID-19 test that resulted in positive. On Monday 28 2022 I contacted my PCP who prescribed an antiviral I began taking the antiviral on Tuesday November 29 and began to see a reduction in symptoms by Thursday December first symptoms had dissipated other than a loss of taste and smell.
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Tinnitus
Clinical narrative: Symptoms began Saturday November 26th at two AM, they include up to 102 degrees, headaches, body aches chills slight congestion and then around eight PM the same I experienced confusion and ringing in the ears. Sunday November 27 2022 I took a home COVID-19 test that resulted in positive. On Monday 28 2022 I contacted my PCP who prescribed an antiviral I began taking the antiviral on Tuesday November 29 and began to see a reduction in symptoms by Thursday December first symptoms had dissipated other than a loss of taste and smell.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Respiratory symptom
Clinical narrative: Hospitalization for upper respiratory symptoms due to COVID-19 on dates 11/28/2022- 12/4/2022.  Treated with Remdesivir.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Hospitalization for COVID-19 on dates 11/29/2022- 12/4/2022. Treated with dexamethasone, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test positive, General symptom
Clinical narrative: 7/15/22 Noticed she started needing her allergy medicine more frequently than normal. About another month later, I began giving her Flonase to help with her symptoms and as needed cough and cold medicine. Her symptoms were a lot worse than they used to be. About a month ago, we had an appointment with an Allergy Specialist. He went over her symptoms, did allergy tests and changed her medicines. He put her on hydroxyzine and increased her Flonase to the maximum dose. A few weeks later he gave her a prescription for a steroid for a few days.  She is a little bit better now, but still not back at base line.
Age: 88.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: No physical side effects but no protection for omicron strand of Covid-19 variant.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Gait disturbance, Gout, Impaired work ability, Joint swelling
Clinical narrative: Had arthritis in right knee. Friday morning began to feel like gout. Had pharmacy request Colchicine from my GP. By Monday couldn't walk very well pain in all joints on right side. Took 2 0.6 mg Colchicine followed with 0.6 an hour later for acute attack.  Tuesday night big Toe joint swelled and red. By Wednesday couldn't walk had to stay home from work. Acute dosage didn't work. By today pain subsiding except for the initial knee arthritis.  In my opinion the Bivalent booster triggered an acute gout attack.
Age: 98.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No physical side effects but no protection for omicron strand of Covid-19 variant.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Immunisation reaction, Rash
Clinical narrative: Per hospital event reporting system " Patient received COVID Moderna Booster on 11/18/22, called into the office today to report an adverse effect from vaccine. Patient reported a rash to both arms and legs starting on Saturday 11/19/22, after receiving the Moderna Booster."
Age: 33.0
Sex: M
Vaccine: COVID19-2
Symptoms: Condition aggravated, Exercise tolerance decreased, Tendonitis
Clinical narrative: I was training for a half marathon at time of the vaccination. I was likely *over*-training as I had increased my distance and speed too quickly. I had run 21 miles in the week leading up to my vaccination and been running higher mileages and faster paces than my previous baseline for about 2 months prior.   Two days after the vaccination, I began to feel what has now been diagnosed as tendinitis in my left posterior tibialis. I have been unable to run since the injury. I am still experiencing symptoms 3 months later after attempting to conservatively manage and treat it myself and am now starting physical therapy.   The injury was very likely just an over-use injury from all the running I was doing without proper cross training and too quick of a ramp-up. However, my sports medicine doctor in December mentioned the timing of the vaccination could have worsened the tendinitis by creating some additional temporary inflammation in my body.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 1/20/21, 2/17/21, 10/21/21, 6/14/22. Positive on 12/2/22
Age: 1.08
Sex: F
Vaccine: MMRV
Symptoms: Wrong product administered
Clinical narrative: Client was given MMRV instead of MMR vaccine along with Varicella vaccine for One year old shots. Writer had mistaken MMRV for MMR vaccine and grabbed wrong vaccine out of the freezer. Client's mother was contacted and explained the situation and educated to monitor client  for adverse reactions or strong immune response.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Concussion, Disturbance in attention, Fatigue
Clinical narrative: I was in good health, had a breakthrough case of Covid, tested positive on 10/28/2022. Had fatigue, chill, and body ache for about 24 hours after injection. I have residual concentration issues and memory issues. I also got a concussion after bumping head.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Head injury, Memory impairment, Pain, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: I was in good health, had a breakthrough case of Covid, tested positive on 10/28/2022. Had fatigue, chill, and body ache for about 24 hours after injection. I have residual concentration issues and memory issues. I also got a concussion after bumping head.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case J&J 4/6/21 041A21A and 12/17/21 213D21A
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Cough, Fatigue, Oropharyngeal pain
Clinical narrative: During the evening of the 09/18/22 I had chills and body ache. I woke up on 09/19/22 and had a sore throat, felt fatigued the chills were still there and the body aches were even worse, I had a low-grade fever. I home COVID-19 test that came back positive very fast. I called my PCP as soon as it was positive to let him know I tested positive. He advised me as to which medications to stop taking, the one I needed to cut in half and I started PAXLOVID immediately. I started feeling better in a couple of days from body aches and fatigue, by 09/23/22 I felt better. I did get rebound COVID-19 but finally was able to feel like myself 12/06/22. I do still have a bit of a lingering cough.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: During the evening of the 09/18/22 I had chills and body ache. I woke up on 09/19/22 and had a sore throat, felt fatigued the chills were still there and the body aches were even worse, I had a low-grade fever. I home COVID-19 test that came back positive very fast. I called my PCP as soon as it was positive to let him know I tested positive. He advised me as to which medications to stop taking, the one I needed to cut in half and I started PAXLOVID immediately. I started feeling better in a couple of days from body aches and fatigue, by 09/23/22 I felt better. I did get rebound COVID-19 but finally was able to feel like myself 12/06/22. I do still have a bit of a lingering cough.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 13 days beyond use date
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 13 days beyond use date
Age: 23.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 12 days beyond use date
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blindness, Headache, Myalgia, Ophthalmological examination abnormal, Retinal infarction
Clinical narrative: When I woke up the following morning after dose five of my COVID-19 I had muscle aches and headaches. I work at a hospital and at about nine or ten AM that morning my vision diminished rapidly. At around ten AM as I was driving home, I called all my doctors. My eye doctor was the only doctor I heard back from on Wednesday November seventh 2022 and he scheduled an appointment for today Friday December ninth 2022. The vision loss has improved although still present as of today. I learned today I have an infarcted retinal artery.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Visual impairment
Clinical narrative: When I woke up the following morning after dose five of my COVID-19 I had muscle aches and headaches. I work at a hospital and at about nine or ten AM that morning my vision diminished rapidly. At around ten AM as I was driving home, I called all my doctors. My eye doctor was the only doctor I heard back from on Wednesday November seventh 2022 and he scheduled an appointment for today Friday December ninth 2022. The vision loss has improved although still present as of today. I learned today I have an infarcted retinal artery.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: Pt should have received the Gray Cap Moderna Booster Vaccine. Instead got a booster dose 0.25ml of the Original Moderna Pediatric. Parent and pediatrician were contacted. No adverse event reported with this medication error. Parent instructed to get little one revaccinated with the correct Moderna booster in 2 months.
Age: 49.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 9 days beyond use date
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Epistaxis, Oropharyngeal pain, Pyrexia
Clinical narrative: 07/03/2022 She had a cough and a low fever, 99.3. She tested positive for COVID with at home test. The next day her fever went up to a little bit, around 99.7.  She had a sore throat and the cough still. The next day, she began to feel better. She had a little bit of a cough, but no sore throat or fever.  For two weeks, she had nose bleeds. We called her pediatrician for her nose bleed.  He said to put petroleum jelly in her nostrils.  Her cough lingered for several months. She has had nose bleeds off and on since, maybe once or twice a month. We took her to the doctor for her cough in the middle of September. The doctor did not prescribe anything but said to give her children?s Zyrtec. That seems to have helped. The cough has now gone away.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 07/03/2022 She had a cough and a low fever, 99.3. She tested positive for COVID with at home test. The next day her fever went up to a little bit, around 99.7.  She had a sore throat and the cough still. The next day, she began to feel better. She had a little bit of a cough, but no sore throat or fever.  For two weeks, she had nose bleeds. We called her pediatrician for her nose bleed.  He said to put petroleum jelly in her nostrils.  Her cough lingered for several months. She has had nose bleeds off and on since, maybe once or twice a month. We took her to the doctor for her cough in the middle of September. The doctor did not prescribe anything but said to give her children?s Zyrtec. That seems to have helped. The cough has now gone away.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Fatigue, Headache, Injection site pain, Injection site swelling
Clinical narrative: Sore arm and mild swelling at injection site, starting about 12 hours after vaccine administration, and lasting about 30 hours.. Mild headache, achy joints, fatigue starting about 20 hours after vaccine administration, and lasting about 24 hours.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 13 days after beyond use date.
Age: 89.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 7 days beyond use date
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: The patient received a second dose of the vaccine and was only was only correspondent to one dose 10/15/2022 second dose 11/22/2022.
Age: 40.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Induration, Nodule, Rash
Clinical narrative: 2-3 days after receiving dose 1 of monkeypox (mpox) vaccine on right forearm, began to have small, hard bumps that were present in medial aspect of right upper arm. No erythema. Skin colored nodules that were ~4-5mm wide. The nodules would come and go. No lymphadenopathy. Total # of nodules was 7-8.
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was given 13 days after beyond use date
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 7 days beyond use date
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 7 days after beyond use date.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine above, with expiration date of 11/30/22 was administered IM on 12/8/2022 by medical assistant.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 7 days beyond use date
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had expired on 11/30/22 when administered to patient
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 14 days after beyond use date.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Asthenia, Atrial fibrillation, Condition aggravated, Diarrhoea, Electrolyte imbalance
Clinical narrative: On 12/06/2022 at around 02:00PM. I was vomiting and I had diarrhea for 8 hours. On 12/07/2022 around 02:30PM I went to the emergency room. The stomach virus caused me to have AFIB. My electrolyte's were out and I felt weak. They gave me 2 diltiazem and IV fluids. After 6 hours I was discharged from the hospital. It happened 1 month after my 5th dose. The Cardiologist have remote monitoring on my pace maker so they can see everything happening to my body. My heart was racing so they changed medications around to control it. I am still under treatment for AFIB.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Gastroenteritis viral, SARS-CoV-2 test negative, Vomiting
Clinical narrative: On 12/06/2022 at around 02:00PM. I was vomiting and I had diarrhea for 8 hours. On 12/07/2022 around 02:30PM I went to the emergency room. The stomach virus caused me to have AFIB. My electrolyte's were out and I felt weak. They gave me 2 diltiazem and IV fluids. After 6 hours I was discharged from the hospital. It happened 1 month after my 5th dose. The Cardiologist have remote monitoring on my pace maker so they can see everything happening to my body. My heart was racing so they changed medications around to control it. I am still under treatment for AFIB.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: states she developed sx and tested positive on home antigen test 12/8/2022 has completed primary series of Moderna- no boosters rec'd
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 6 days after beyond use date.
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse reactions occurred. Patient received Bivalent Pfizer booster instead of Monovalent as first dose in vaccination series.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 7 days beyond use date
Age: 6.0
Sex: M
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: The vaccine patient recieved had expired on 11/30/22.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Headache, Pain
Clinical narrative: I had bilateral sinus pressure in my face, headache, fatigue, body aches and chills. I also had head congestion. I spoke to my doctor after testing positive 11-28-2022. They advised me to take vitamin D, vitamin C, and PEPCID. My symptoms started to resolve by the next day. I still have a little congestion. My symptoms have not totally resolved.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Paranasal sinus discomfort, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had bilateral sinus pressure in my face, headache, fatigue, body aches and chills. I also had head congestion. I spoke to my doctor after testing positive 11-28-2022. They advised me to take vitamin D, vitamin C, and PEPCID. My symptoms started to resolve by the next day. I still have a little congestion. My symptoms have not totally resolved.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 7 days beyond use date
Age: 91.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 6 days after beyond use date.
Age: 54.0
Sex: M
Vaccine: COVID19-2
Symptoms: Device connection issue, Syringe issue
Clinical narrative: While giving a Covid vaccine needle and hub separated from the syringe and product went on pts arm instead of in.  Re vaccinated him.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 13 days beyond use date
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 19 days after beyond use date.
Age: 48.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 6 days after beyond use date.
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 6 days beyond use date
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: She received a Second Dose that was not correspondent to her. It was only one and the second was given as first dose: 10/13/2022  which this second dose did not correspond to her because it was monovalent 11/22/2022
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Laboratory test normal, Palpitations
Clinical narrative: I did not have a reaction to the vaccine. I have had heart palpitations for 30 years. I noticed that after the vaccine, they progressed in intensity and frequency. I went to my primary care doctor and was referred to a cardiologist. I had several tests all of which resulted in within normal range. I was given a prescription for metoprolol to relieve my symptoms.
Age: 57.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 14 days beyond use date
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Admitted to medical and then transferred to Hospital. Tested positive 12/4/22 with unknown symptom onset. Treatment includes transitional care for weakness.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 19 days beyond use date.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 5 days beyond use date
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Heart rate increased
Clinical narrative: Rapid heart rate the next morning upon waking, heart rate up to 124 BPM while doing nothing, also felt light headed for a couple minutes when sitting down on the toilet.  I took a propranolol 10mg around 8:55 am. I went to the urgent care to make sure I wasn't having an allergic reaction. I ended up taking my propranolol at the urgent care and waited to make sure I felt better after taking it. I left about 9:30. My heart rate went back down to mid 80's.  So they let me leave. My heart rate went back up for a little bit while driving home, 113bpm. Then back down when I got home. My heart rate went up upon waking  each day until Sunday, but the episodes were not as bad as each day went by. I took a propranolol pill each day it happened. When my heart rate goes up like that I also feel abnormal, and I'll get sort of a headache, and sometimes light headed.
Age: 60.0
Sex: M
Vaccine: FLU4
Symptoms: Unevaluable event
Clinical narrative: Patient has a history of Guillain-Barre.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 6 days after beyond use date.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: 10/30/2022 I had a scratchy throat. 10/31 I woke up with a headache, brain fog, scratchy throat, fatigue, loss sense of smell and taste, nausea, and diarrhea. Tested on an at home COVID-19 test, positive. Tele visit with doctor. Doctor prescribed albuterol inhaler, Z-PAK, PAXLOVID, BROMFED cough medication. By 5th day, November 5th symptoms were very reduced. After PAXLOVID, I felt better. Once PAXLOVID was out, symptoms returned and got worse. This is when the doctor proscribed the Z-PAK. Symptoms gradually improved until November 19th when I felt better. Still lingering headache, sinus and nasal drainage, with occasional nausea.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Feeling abnormal, Headache, Nausea, Paranasal sinus hypersecretion
Clinical narrative: 10/30/2022 I had a scratchy throat. 10/31 I woke up with a headache, brain fog, scratchy throat, fatigue, loss sense of smell and taste, nausea, and diarrhea. Tested on an at home COVID-19 test, positive. Tele visit with doctor. Doctor prescribed albuterol inhaler, Z-PAK, PAXLOVID, BROMFED cough medication. By 5th day, November 5th symptoms were very reduced. After PAXLOVID, I felt better. Once PAXLOVID was out, symptoms returned and got worse. This is when the doctor proscribed the Z-PAK. Symptoms gradually improved until November 19th when I felt better. Still lingering headache, sinus and nasal drainage, with occasional nausea.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Throat irritation
Clinical narrative: 10/30/2022 I had a scratchy throat. 10/31 I woke up with a headache, brain fog, scratchy throat, fatigue, loss sense of smell and taste, nausea, and diarrhea. Tested on an at home COVID-19 test, positive. Tele visit with doctor. Doctor prescribed albuterol inhaler, Z-PAK, PAXLOVID, BROMFED cough medication. By 5th day, November 5th symptoms were very reduced. After PAXLOVID, I felt better. Once PAXLOVID was out, symptoms returned and got worse. This is when the doctor proscribed the Z-PAK. Symptoms gradually improved until November 19th when I felt better. Still lingering headache, sinus and nasal drainage, with occasional nausea.
Age: 32.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Dry throat, Epistaxis, Headache, Oropharyngeal pain
Clinical narrative: December second 2022 I had a slight headache and a slight dry throat on the fourth of December 2022 I had a slight dry throat and headache then in the evening around eleven PM I tested positive with a COVID-19 antigen test. On the fifth of December I had a 102 degree fever and a more severe sore throat with a bit of phlegm and blood that I produced through my nose, after some sleep my fever reduced to 100 degrees, the same day my doctor prescribed PAXLOVID which I started that evening and I mostly had the same symptoms with the fever gone and then the next few days after that I stayed at home from work resting and hydrating with symptoms improving.
Age: 32.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: December second 2022 I had a slight headache and a slight dry throat on the fourth of December 2022 I had a slight dry throat and headache then in the evening around eleven PM I tested positive with a COVID-19 antigen test. On the fifth of December I had a 102 degree fever and a more severe sore throat with a bit of phlegm and blood that I produced through my nose, after some sleep my fever reduced to 100 degrees, the same day my doctor prescribed PAXLOVID which I started that evening and I mostly had the same symptoms with the fever gone and then the next few days after that I stayed at home from work resting and hydrating with symptoms improving.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 19 days after beyond use date.
Age: 17.0
Sex: M
Vaccine: HEP, HPV9, IPV, MMR, TD, VARCEL
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: There were no adverse effects after 48 hours of follow-up.